Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

BACKGROUND: Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction. Recent small-scaled studies have suggested that intracoronary administration of abciximab during...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Youlan L, Fokkema, Marieke L, Kampinga, Marthe A, de Smet, Bart JGL, Tan, Eng S, van den Heuvel, Ad FM, Zijlstra, Felix
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765937/
https://www.ncbi.nlm.nih.gov/pubmed/19785725
http://dx.doi.org/10.1186/1745-6215-10-90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765937/
https://www.ncbi.nlm.nih.gov/pubmed/19785725
http://dx.doi.org/10.1186/1745-6215-10-90

Ejemplares similares